Calgary-based company’s COVID-19 vaccine heading into human clinical trials
CEO of Providence Therapeutics, Brad Sorenson, joins Linda Olsen to discuss a new COVID-19 vaccine developed by the Calgary-based company as it heads into human clinical trials.